
Doximity (DOCS) Stock Forecast & Price Target
Doximity (DOCS) Analyst Ratings
Bulls say
Doximity is a unique and valuable platform for physicians and other healthcare professionals, offering digital solutions for collaboration, career management, and virtual patient visits. The company's strong customer renewal rates and potential for expansion in existing accounts reflect the value of their services and the high level of satisfaction among its customers. The recent growth in AI search and AI scribe products further demonstrate the potential for increased revenue and retention as healthcare continues to shift towards digital solutions. While investments in AI may temporarily impact margins, the long-term potential for growth and market expansion make Doximity's stock a promising investment opportunity for those with a positive outlook.
Bears say
Doximity is expected to face challenges in its growth due to constraints in pharma budgets and increasing competition in their AI search and scribe products. The company's conservative approach in forecasting for the upcoming year adds to the negative outlook, with a lowered PT to $27. Although the company has strong margins and free cash flow, these may not be enough to offset slower growth and challenges in member engagement, particularly in a market with growing competition and budget constraints.
This aggregate rating is based on analysts' research of Doximity and is not a guaranteed prediction by Public.com or investment advice.
Doximity (DOCS) Analyst Forecast & Price Prediction
Start investing in Doximity (DOCS)
Order type
Buy in
Order amount
Est. shares
0 shares